Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0ZL9I
|
||||
| Former ID |
DNC014366
|
||||
| Drug Name |
9-O-[3-(4-Bromo-phenoxyl)butyl]-berberine bromide
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [530920] | ||
| Formula |
C29H27Br2NO5
|
||||
| Canonical SMILES |
COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC5=C(C=C4CC3)OCO5)OCCCC<br />OC6=CC=C(C=C6)Br.[Br-]
|
||||
| InChI |
1S/C29H27BrNO5.BrH/c1-32-26-9-4-19-14-25-23-16-28-27(35-18-36-28)15-20(23)10-11-31(25)17-24(19)29(26)34-13-3-2-12-33-22-7-5-21(30)6-8-22;/h4-9,14-17H,2-3,10-13,18H2,1H3;1H/q+1;/p-1
|
||||
| InChIKey |
GJHATLDZFZXPEQ-UHFFFAOYSA-M
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Cholinesterase | Target Info | Inhibitor | [530920] | |
| Acetylcholinesterase | Target Info | Inhibitor | [530920] | ||
| KEGG Pathway | Glycerophospholipid metabolism | ||||
| Cholinergic synapse | |||||
| PANTHER Pathway | Muscarinic acetylcholine receptor 1 and 3 signaling pathway | ||||
| Muscarinic acetylcholine receptor 2 and 4 signaling pathway | |||||
| Nicotinic acetylcholine receptor signaling pathwayP00042:Muscarinic acetylcholine receptor 1 and 3 signaling pathway | |||||
| Nicotinic acetylcholine receptor signaling pathway | |||||
| Pathway Interaction Database | ATF-2 transcription factor network | ||||
| PathWhiz Pathway | Phospholipid Biosynthesis | ||||
| References | |||||